Skip to content

Alamar Biosciences ALMR Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Simon Property Group logo
Simon Property GroupSPG
$738.03M
Blackstone logo
BlackstoneBX
$786.28M-2.6%
TG Therapeutics logo
TG TherapeuticsTGTX
$6.48M-6.4%
3M logo
3MMMM
$558M-4.9%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.9%0.0pp
VTR
VentasVTR
$293.78M-4.0%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's operating lease ROU assets?
Alamar Biosciences (ALMR) reported operating lease ROU assets of $25.67M in Q1 2026.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.